• IMA sites
    • IMAJ services
    • IMA journals
    • Follow us
    • Alternate Text Alternate Text
    עמוד בית
    Sun, 24.11.24

    Original Articles

    IMAJ | volume

    Journal 7, July 2006
    pages: 469-472

    Colchicine Therapy and the Cognitive Status of Elderly Patients with Familial Mediterranean Fever

      Full article (PDF)

      Summary

      Backgound:

      Colchicine is widely used for treating gout and familial Mediterranean fever. However, studies in animal models have reported ill effects of colchicine on the central nervous system, including cognitive function.

      Objectives:

      To evaluate the cognitive status of elderly FMF[1] patients on long-term colchicine treatment.

      Methods:

      The study group consisted of 55 FMF patients aged 74 ± 5, attending an FMF outpatient clinic and receiving colchicine treatment for 25.1 ± 8.9 years. The Mini-Mental State Examination was used for cognitive evaluation. Patients' scores were compared with accepted age- and education-adjusted cutoff scores, population-based norms, and scores of a matched control group of 56 subjects.

      Results:

      Individually, all colchicine-treated FMF patients scored well above the age- and education-corrected cutoff scores. Overall, there was a large difference, 5.0 ± 1.6, from the expected cutoff points, in favor of the study group scores (P < 0.001). The individual scores of the control group were also above the cutoff points, however with a lower but still statistically significant difference (3.71 ± 1.15 points, P < 0.001). Compared to population-based norms adjusted by age and education, the study group had significantly higher mean MMSE[2] scores (27.2 ± 2.2 vs. 25.5 ± 2.4, P < 0.001). The control group’s scores were also somewhat higher than expected, but not significantly so.

      Conclusions:

      Our results do not support the view that prolonged colchicine treatment may be associated with cognitive impairment. On the contrary, it is possible that long-term colchicine treatment may even confer protection against cognitive decline in patients with FMF.

       

      [1] FMF = familial Mediterranean fever
      [2] MMSE = Mini-Mental State Examination

      Full article (PDF)
      About Imaj About Imaj Editorial Board
      Online Tools Submit a Manuscript Subscribing to IMAJ
      Contact Us Imaj Editorial 03-6100418 Fax 03-7519673 Service Center 03-6100471 Contact us by Online Form
      About IMA What is the Israeli Medical Association? IMA Site IMA Historical Background The IMA Vision
      Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
      The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
      © All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

      2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel
      SLATECH - פיתוח אתרי אינטרנט ופורטלים ארגוניים המערכת פותחה על ידי חברת